“…MPI has been used in several in vivo application domains to date, including cell tracking (Zheng, Vazin, et al 2015; Zheng, See, et al 2016), cancer imaging (Yu et al 2016), blood pool and perfusion imaging (Orendorff et al 2016), angiography and cardiac imaging (J Weizenecker et al 2009), lung ventilation and perfusion studies (Nishimoto et al 2015; Zhou et al 2016), and predicting the effect of MFH (Kuboyabu et al 2016). These results highlight the strengths of MPI: zero background signal, zero depth attenuation of the signal, high sensitivity, linear quantification, and no half-life associated with the tracer signal such that physiologic clearance times determine the time horizons available in longitudinal studies.…”